• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸苷酸合成酶肽抑制剂在卵巢癌细胞中的内化和稳定性。

Internalization and stability of a thymidylate synthase Peptide inhibitor in ovarian cancer cells.

机构信息

Department of Life Sciences, University of Modena and Reggio Emilia , Via Campi 183, 41125 Modena, Italy.

出版信息

J Med Chem. 2014 Dec 26;57(24):10551-6. doi: 10.1021/jm501397h. Epub 2014 Dec 3.

DOI:10.1021/jm501397h
PMID:25353379
Abstract

Information on the cellular internalization and stability of the ovarian cancer cell growth inhibitor peptide, LSCQLYQR (LR), is vital for lead optimization. Ad-hoc-synthesized LR/fluorescent-probe conjugates were used to monitor the internalization of the peptide. Mass spectrometry was used to identify adducts resulting from the thiol reactivity of the cysteine residue in LR. A mechanistic model is proposed to explain the observed change in intracellular peptide amount over time. Structural modifications can be foreseen to improve the peptide stability.

摘要

对于先导优化,了解卵巢癌细胞生长抑制剂肽 LSCQLYQR(LR)的细胞内化和稳定性信息至关重要。专门合成的 LR/荧光探针缀合物用于监测肽的内化。质谱用于鉴定 LR 中半胱氨酸残基的巯基反应生成的加合物。提出了一个机制模型来解释观察到的细胞内肽含量随时间的变化。可以预见结构修饰可以提高肽的稳定性。

相似文献

1
Internalization and stability of a thymidylate synthase Peptide inhibitor in ovarian cancer cells.胸苷酸合成酶肽抑制剂在卵巢癌细胞中的内化和稳定性。
J Med Chem. 2014 Dec 26;57(24):10551-6. doi: 10.1021/jm501397h. Epub 2014 Dec 3.
2
A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells.载肽型胸苷酸合成酶抑制剂的聚乙二醇脂质体增强化疗药物在人卵巢癌细胞中的抗肿瘤作用。
Int J Mol Sci. 2020 Jun 23;21(12):4452. doi: 10.3390/ijms21124452.
3
BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors.BGC 945,一种新型的肿瘤选择性胸苷酸合成酶抑制剂,靶向α-叶酸受体过表达的肿瘤。
Cancer Res. 2005 Dec 15;65(24):11721-8. doi: 10.1158/0008-5472.CAN-05-2034.
4
Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth.脯氨酸突变 LR 肽抑制人胸苷酸合成酶和卵巢癌细胞生长的构象倾向和生物学研究。
J Med Chem. 2018 Aug 23;61(16):7374-7380. doi: 10.1021/acs.jmedchem.7b01699. Epub 2018 Aug 13.
5
Folic Acid-Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface Targeting.叶酸-肽缀合物将选择性癌细胞内化与胸苷酸合成酶二聚体界面靶向结合。
J Med Chem. 2021 Mar 25;64(6):3204-3221. doi: 10.1021/acs.jmedchem.0c02107. Epub 2021 Mar 12.
6
Enhanced anti-hyperproliferative activity of human thymidylate synthase inhibitor peptide by solid lipid nanoparticle delivery.通过固体脂质纳米粒递送增强人胸苷酸合成酶抑制剂肽的抗增殖活性。
Colloids Surf B Biointerfaces. 2015 Dec 1;136:346-54. doi: 10.1016/j.colsurfb.2015.09.040. Epub 2015 Sep 25.
7
Optimization of peptides that target human thymidylate synthase to inhibit ovarian cancer cell growth.优化靶向人胸苷酸合成酶的肽以抑制卵巢癌细胞生长。
J Med Chem. 2014 Feb 27;57(4):1355-67. doi: 10.1021/jm401574p. Epub 2014 Feb 12.
8
Cyclic Peptides Acting as Allosteric Inhibitors of Human Thymidylate Synthase and Cancer Cell Growth.环肽作为人类胸苷酸合成酶和癌细胞生长的变构抑制剂。
Molecules. 2019 Sep 26;24(19):3493. doi: 10.3390/molecules24193493.
9
Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase.蛋白-蛋白界面结合肽抑制癌症治疗靶点人胸苷酸合成酶。
Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):E542-9. doi: 10.1073/pnas.1104829108. Epub 2011 Jul 27.
10
Inhibitor of ovarian cancer cells growth by virtual screening: a new thiazole derivative targeting human thymidylate synthase.通过虚拟筛选抑制卵巢癌细胞生长:一种针对人胸苷酸合成酶的新型噻唑衍生物。
J Med Chem. 2012 Nov 26;55(22):10272-6. doi: 10.1021/jm300850v. Epub 2012 Nov 5.

引用本文的文献

1
Peptides for diagnosis and treatment of ovarian cancer.用于卵巢癌诊断和治疗的肽。
Front Oncol. 2023 May 5;13:1135523. doi: 10.3389/fonc.2023.1135523. eCollection 2023.
2
Folic Acid-Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface Targeting.叶酸-肽缀合物将选择性癌细胞内化与胸苷酸合成酶二聚体界面靶向结合。
J Med Chem. 2021 Mar 25;64(6):3204-3221. doi: 10.1021/acs.jmedchem.0c02107. Epub 2021 Mar 12.
3
Cyclic Peptides Acting as Allosteric Inhibitors of Human Thymidylate Synthase and Cancer Cell Growth.
环肽作为人类胸苷酸合成酶和癌细胞生长的变构抑制剂。
Molecules. 2019 Sep 26;24(19):3493. doi: 10.3390/molecules24193493.
4
Intracellular quantitative detection of human thymidylate synthase engagement with an unconventional inhibitor using tetracysteine-diarsenical-probe technology.使用四半胱氨酸-二砷探针技术对人胸苷酸合成酶与一种非常规抑制剂的细胞内定量检测。
Sci Rep. 2016 Jun 2;6:27198. doi: 10.1038/srep27198.
5
Deoxyribonucleotide metabolism, mutagenesis and cancer.脱氧核苷酸代谢、突变与癌症。
Nat Rev Cancer. 2015 Sep;15(9):528-39. doi: 10.1038/nrc3981.